Programma van Live Uitzending 'Supertrends & Disruptieve Innovatie in Vermogensbeheer post-Covid-19'
Live Uitzending 'Supertrends & Disruptieve Innovatie in Vermogensbeheer post-Covid-19'
Op dinsdag 13 april: | |
14:00 - 14:10 |
Welkomstwoord & Inleiding
Fons Lute, Investment Consultant, Asset Ideas |
14:10 - 14:40 |
What to buy and hold for a post-COVID-19 world? (Macroeconomic outlook)
Jan Loeys, Managing Director and Senior Advisor, Long-Term Strategy, J.P. Morgan |
14:40 - 15:10 |
Fintech and the e-Commerce Tailwind during and post Covid-19
Anjali Bastianpillai, Senior Product Specialist, Pictet Asset Management Anjali Bastianpillai will address the drivers behind the huge acceleration of the development of e-commerce and financial commerce, due to the pandemic. |
15:10 - 15:40 |
Sustainable Energy Transition can lead to disruption
Sebastiaan Masselink, Senior Investment Manager Impact Investing, ACTIAM S-curves depict the phenomenon of a technology which takes many years to build market momentum and then suddenly grows to dominant market shares. Volumes push down prices, which triggers more demand and pushes out old business models. Well known example once was the smart phone, but we have seen the same happening in solar- and wind-power. Electrical vehicles and adjacent (charging) infra structure have embarked on the same route. Energy storage and self-driving vehicles will be next in the foreseeable future. We will give insights in the investment risks and opportunities with regards to private investments in the sustainable energy transition. |
15:40 - 16:00 | Pauze |
16:00 - 16:30 |
Sustainable Research in a Post-COVID World
Toby Gibb, Head of Investment Directing - Equities, Fidelity International During this session you will get some useful insights in how to improve your portfolio based on data driven research and ongoing engagements with companies. You’ll be introduced to an easy tool: the portfolio health check. |
16:30 - 17:00 |
Paneldiscussie over ‘Hoe speel je optimaal in op beleggingskansen post-Covid-19?’
|